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ABSTRACT Caffeine potentiates the mutagenic and lethal
effects of genotoxic agents. It is thought that this is due, at least
in some organisms, to inhibition of DNA repair. However,
direct evidence for inhibition of repair enzymes has been
lacking. Using purified Escherichia coli DNA photolyase and
(A)BC excinuclease, we show that the drug inhibits photore-
activation and nucleotide excision repair by two different
mechanisms. Caffeine inhibits photoreactivation by interfering
with the specific binding of photolyase to damaged DNA, and
it inhibits nucleotide excision repair by promoting nonspecific
binding of the damage-recognition subunit, UvrA, of (A)BC
excinuclease. A number of other intercalators, including acri-
flavin and ethidium bromide, appear to inhibit the excinuclease
by a similar mechanism-that is, by trapping the UvrA subunit
in nonproductive complexes on undamaged DNA.
Caffeine has a myriad of pharmacological effects. Among
these, the sensitization of cells to the lethal and mutagenic
effects of DNA-damaging agents has been the subject of
numerous studies in the last three decades (1-5). It has been
suggested that caffeine binds to DNA-perhaps with higher
affinity to damaged regions (6)-and thus interferes with the
specific binding of repair enzymes (4). However, none of the
repair proteins that have been purified and tested, Micro-
coccus luteus UV endonuclease (7), Escherichia coli 3-
methyladenine DNA glycosylase I (8), and human placental
AP endonuclease (9), were inhibited by caffeine. In E. coli,
caffeine at 10-100 mM inhibits photoreactivation in vivo (3)
and nucleotide excision repair in vivo (1) and in a permeabi-
lized cell system (10).
Photoreactivation is the reversal of the mutagenic and
lethal effects of far UV by subsequent exposure of cells to
near UV or visible light (11). The phenomenon is mediated by
photoreactivating enzyme, DNA photolyase. This enzyme
repairs DNA by breaking the cyclobutane ring of pyrimidine
dimers (80-90%o of the total UV photoproducts) in a light-
driven reaction. The enzyme binds to pyrimidine dimers in a
light-independent reaction and, upon absorbing a photon of
photoreactivating light (300-500 nm), donates an electron to
the dimer, initiating an electronic reorganization which even-
tually produces two intact pyrimidines (11). In contrast to
photoreactivation, which repairs pyrimidine dimers in situ,
nucleotide excision repair entails the removal of a segment of
the DNA backbone containing the damaged base(s) followed
by filling in of the gap by DNA polymerase and sealing by
ligase. In addition to removing pyrimidine dimers, this repair
mechanism is responsible for removal of DNA adducts of a
wide variety of chemicals such as psoralen, cisplatin, and
mitomycin C (11). In E. coli, nucleotide excision is initiated
by an ATP-dependent nuclease, the (A)BC excinuclease,*
which incises the eighth phosphodiester bond 5' and the
fourth phosphodiester bond 3' to the adducted nucleotide(s).
In this study we have used defined DNA substrates, purified
photoreactivating enzyme, DNA photolyase, and the nucle-
otide excision repair enzyme (A)BC excinuclease to inves-
tigate the mechanism of repair inhibition by caffeine in E.
coli. A preliminary account of this study has been published
(12).
MATERIALS AND METHODS
Enzymes and Substrates. Photolyase and the three subunits
of (A)BC excinuclease were purified as described previously
(13, 14). The substrate for photolyase was a 48-base-pair (bp)
duplex containing a centrally located thymine dimer and a 32p
label on the 5' terminus of the damaged strand (15). The
substrate for (A)BC excinuclease was either UV-irradiated
(130 J/m2) 3H-labeled pBR322 or a 137-bp duplex which was
terminally labeled and contained a centrally located psoralen
monoadduct (16).
DNase I "Footprinting."1 For photolyase footprinting, re-
action mixtures (50 .ul) containing 50 mM Tris HCl at pH 7.5,
50 mM NaCl, 1 mM dithiothreitol, bovine serum albumin at
100 ,ug/ml, 10 nM photolyase, ~1 nM DNA substrate, and
the indicated amounts of caffeine were incubated for 20-25
min in the dark. After incubation certain samples were
exposed to photoreactivating light from a camera flash (17),
MgCl2 (10 mM) and CaC12 (5 mM) were then added to each
sample, and the DNA was digested with DNase I (Bethesda
Research Laboratories) at 12 ng/ml for 6 min at 23°C. The
DNA was precipitated with ethanol and analyzed on 11%
polyacrylamide sequencing gels.
The UvrA footprinting was carried out in 100 ,ul of ABC
reaction buffer (50mM Tris-HCl, pH 7.5/50mM KCl/10 mM
MgCI2/2 mM ATP/1 mM dithiothreitol/50 ,ug of bovine
serum albumin per ml) containing 6 nM UvrA, ':2 nM DNA,
and the indicated amounts of caffeine. The mixtures were
incubated for 25 min at 23°C, then CaC12 (2.5 mM) and DNase
I (5.6 ng/ml) were added, and after 5 min of incubation the
DNA was precipitated with ethanol and analyzed on 8%
polyacrylamide sequencing gels.
Incision Assay. This assay measures the conversion of
supercoiled DNA to open circular form as a result of nicking
by (A)BC excinuclease. The reaction mixtures (in 100 ,ul of
ABC buffer) contained 170 fmol of UV-irradiated pBR322 (or
nonirradiated control DNA), 170 fmol of UvrA, 6 pmol of
UvrB, 12 pmol of UvrC, and, when indicated, 10 mM
caffeine. The mixtures were incubated at 37°C and at time
intervals 12.5-,ul aliquots were taken and the reaction was
stopped by adding SDS to 0.2%. The samples were heated at
65°C for 5 min and then the DNA was separated on 0.8%
agarose gels, superhelical and open circular forms were
located by staining with ethidium bromide, and the DNA was
*We use the name "(A)BC excinuclease" for the nuclease activity
resulting from the mixture of UvrA, UvrB, and UvrC proteins ofE.
coli. The UvrA subunit delivers UvrB to the damage site and then
dissociates from DNA; the actual nuclease complex, therefore,
includes only UvrB and UvrC; hence A is in parentheses to indicate
that it is essential for the nuclease activity but is not present in the
actual nuclease complex.
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cut out and quantified by scintillation counting. The average
number of incisions per plasmid was calculated by using the
Poisson distribution (18).
RESULTS AND DISCUSSION
Inhibition of Photoreactivation. The effect of caffeine on
photolyase was investigated by DNase I footprinting on a
48-bp-long duplex containing a uniquely located thymine
dimer. The result is shown in Fig. 1. In the absence ofcaffeine
photolyase binds to the thymine dimer, producing a DNase I
footprint of about 15 bp (lane 2). When the photolyase/DNA
mixture is exposed to an intense flash of photoreactivating
light, nearly all ofthe substrate is repaired and treatment with
DNase I (i) reveals two new bands that are diagnostic of
repaired substrate (the lower of these two bands is marked
with the letter A) and (ii) fails to show any footprint as
evidenced by the reappearance of band B, which was nearly
completely absent in the nonphotoreactivated lane. Band C
in Fig. 1 is unaffected by photolyase and is used as an internal
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standard in comparing lanes to one another. In the presence
of caffeine the photolyase footprint gradually disappears with
increasing concentrations ofthe drug (compare the intensities
of band B in lanes 2, 4, 6, 8, and 10) and there is a
corresponding decrease in photorepair as evidenced by de-
creasing intensity of band A in lanes 5, 7, 9, and 11 as
compared with lane 3. Densitometric scanning of bands A
and B (using band C as an internal standard) indicate that the
decrease in intensity of band A (repair) is associated with an
increase in band B (binding). Thus it appears that caffeine
inhibits photorepair by interfering with photolyase binding
but has no effect on the photochemical reaction per se.
Inhibition of (A)BC Excinuclease. Damage recognition and
removal by (A)BC excinuclease occurs in several stages (18):
the damage-recognition subunit, UvrA, binds to DNA con-
taining pyrimidine dimers or other lesions, delivers the UvrB
subunit to the damaged site, and dissociates from DNA; the
UvrC subunit then binds to the UvrB/damaged DNA com-
plex and incisions are made on both sides of the DNA adduct
and at a distance from it. Caffeine inhibits nicking ofdamaged
DNA by the enzyme both in permeabilized cells (10) and in
vitro (Fig. 2).
Since several steps in the reaction mechanism are ATP
dependent we considered the possibility that the purine
analog caffeine may inhibit the enzyme as a competitive
inhibitor of ATPase function. However, we found (G. Myles
and A.S., unpublished data) that 10mM caffeine has no effect
on the ATPase activity of UvrA, in agreement with perme-
abilized cell experiments which indicated that the inhibition
of nicking was not reversed with higher ATP concentrations
(10). Therefore, we considered alternative mechanisms of
inhibition such as interference with binding of UvrA, the
loading of UvrB, the binding of UvrC to the UvrB/DNA
complex, or incision. To identify the particular step inhibited
by the drug we added caffeine to incision reaction mixtures
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FIG. 1. Caffeine inhibits the specific binding of photolyase to
DNA. Photolyase (10 nM) was mixed with substrate ("1 nM) in 50
,ul of reaction buffer containing the indicated amounts of caffeine.
After incubation for 25 min in the dark certain samples were exposed
to a flash of photoreactivating light (hv), then all DNA samples were
digested with DNase I and analyzed on an 11% polyacrylamide
sequencing gel. ff, thymine dimer; band A is generated by hydrol-
ysis of the phosphodiester bond which joins the thymines that make
up the dimer and its intensity is a measure of photorepair; band B is
protected against DNase I digestion by photolyase and its extent of
disappearance is a measure of photolyase binding; band C is gener-
ated by cleavage of a phosphodiester bond outside the photolyase
binding site and it may be used as an internal control in comparing
the intensities of band A and band B between different lanes.
Caffeine slightly inhibited DNase I digestion at sites indicated by
asterisks. These results were reproduced in several independent
experiments.
FIG. 2. Caffeine inhibits incision of UV-irradiated DNA by
(A)BC excinuclease. The mixtures (100 ,ul) were incubated at 37°C
and at the indicated times 12.5-,ul samples were withdrawn to
quantify incision. o, No caffeine was added; DNA was incubated
with UvrA and UvrB for 12 min and then the incision reaction was
initiated ("zero time") by the addition of UvrC. *, Caffeine was
incubated with DNA for 12 min, UvrA plus UvrB was added, and
after further incubation for 12 min UvrC was added. *, DNA was
incubated with UvrA and UvrB for 12 min and then caffeine and
UvrC were added. The means and standard errors plotted are from
two experiments carried out under indentical conditions. The back-
ground incisions (with undamaged DNA), which ranged from 10 (no
caffeine), 0 (early addition), and 7 fmol (delayed addition) at 3 min to
52 (no caffeine), 28 (early addition), and 14 fmol (delayed addition)
at 50 min, have been subtracted from the specific incisions plotted in
this figure. Note that these values demonstrate that caffeine does not
promote incision of undamaged DNA.
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at various stages of assembly of the enzyme. As is seen in Fig.
2, maximum inhibition is achieved when the drug is added
prior to loading of UvrB onto DNA, which implies that
caffeine interferes with binding of UvrA, delivery of UvrB to
the damaged site, or both. Some inhibition is observed even
with delayed addition of caffeine which might be interpreted
as interference with the binding of UvrC or incision. While
our experiment does not categorically preclude such an
explanation, the most likely cause of the low inhibition with
delayed addition of caffeine is that the delivery of UvrB to
DNA is actually incomplete in 12 min and it continues at a
slower rate for longer times (D. K. Orren and A.S., unpub-
lished observation). Therefore, addition of caffeine 12 min
after UvrA and UvrB would still result in some interference
with loading of UvrB and therefore incision.
Effect of Caffeine on UvrA Binding. We investigated the
binding of UvrA to DNA by DNase I footprinting, using a
137-bp-long duplex containing a uniquely located psoralen
monoadduct (16, 19). The results are shown in Fig. 3. In the
absence of caffeine UvrA binds specifically to the substrate,
yielding a footprint of 33 bp (lane 10); no nonspecific binding
is seen at the UvrA concentration (6 nM) used in these
experiments. Caffeine does not appear to interfere with the
formation of the damage-specific complexes, as indicated by
the presence of a discernible footprint at concentrations of up
to 5 mM (lane 14). Instead, it strongly promotes nonspecific
binding by UvrA as evidenced by the striking protection of
the whole fragment (damaged or undamaged) from DNase I
digestion when both UvrA and caffeine are present. We can
also detect caffeine-dependent binding of UvrA to undam-
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FIG. 3. Caffeine promotes the binding of UvrA to undamaged
DNA. The 137-bp synthetic duplex with or without a psoralen
monoadduct was mixed with UvrA in the presence of 0-25 mM
caffeine, digested with DNase I, and analyzed on an 8% polyacryl-
amide sequencing gel. The bracket indicates the specific UvrA
footprint (lane 10) and the circled T the location of psoralen-adducted
thymine (75 nucleotides from the labeled 5' terminus). Caffeine
slightly enhanced DNase I digestion at sites indicated by asterisks.
aged DNA by using the gel-shift assay (data not shown).
Binding at these sites is nonproductive; that is, it does not
lead to incision upon addition of UvrB and UvrC subunits as
is apparent from the control data listed in the legend of Fig.
2. Furthermore, the presence ofUvrB in the reaction mixture
did not alter UvrA's high-affinity binding to undamagedDNA
(data not shown). Thus we conclude that caffeine inhibits
(A)BC excinuclease by creating additional binding sites for
UvrA which compete with the repairable DNA damage. An
additional effect of caffeine on the delivery of UvrB to
damaged sites, though unlikely, cannot be excluded by our
experiments.
Effect of Other Intercalators on UvrA Binding. In consid-
ering how caffeine traps UvrA we noted that the drug
reportedly intercalates into nucleic acids (20-22), and it
appears to affect the DNase I digestion pattern in our
experiments in the same way that other intercalating com-
pounds affect DNase I digestion: producing a sequence
specific enhancement or inhibition of digestion (23, 24).
These caffeine-enhanced or inhibited digestion sites are in-
dicated by asterisks in Figs. 1 and 3. Therefore, we tested
other intercalators, including some which are known to
inhibit DNA repair in vivo (1, 25), for their effect on UvrA.
We found that ethidium bromide at 1.0 AuM and chloroquine
at 0.2 mM promoted the binding ofUvrA to undamaged DNA
to the same level as 25 mM caffeine under experimental
conditions similar to those in Fig. 3 and as tested by DNase
I footprinting. Comparable results were obtained with acri-
dine orange and acriflavine by using the gel-shift assay (data
not shown). These observations suggest that caffeine pro-
motes UvrA binding by intercalating into DNA. In line with
this conclusion, it has recently been reported that the bifunc-
tional intercalator ditercalinium promotes binding ofUvrA to
DNA (26). However, in contrast with our findings with
caffeine and other intercalators, ditercalinium did promote
enzymatic incision ofDNA by (A)BC excinuclease. This may
be due simply to the extremely high affinity of ditercalinium
to DNA (Kd = 10-7 M) compared to the affinities of the
monointercalators used in our study (Kd 10-3 to 10-i M)
(see ref. 27). Alternatively, the intercalation of two aromatic
rings tethered to one another by a 10- to 15-A linker in
ditercalinium could conceivably give rise to a structure
distinctly different from the structures of monointercalators
and thus contribute to the differential handling of these
structures by (A)BC excinuclease. In addition, it has also
been suggested that UvrA/ditercalinium/DNA complexes
block DNA replication and thus contribute to toxicity (26).
Conclusion. Caffeine is perhaps the most extensively con-
sumed drug, and its genotoxic effects have been the subject
of extensive research and debate. The results presented here
in conjunction with previous reports on DNA-caffeine inter-
actions lead us to conclude that many of the pleitropic genetic
effects of caffeine may be ascribed to the intercalation of the
drug into DNA, which in E. coli causes inhibition of photo-
reactivation by blocking specific enzyme binding and inhibi-
tion of excision repair by increasing nonspecific enzyme
binding. We have also shown that caffeine at 10 mM inhibits
nucleotide excision repair in a HeLa cell-free extract system
(12). However, a 60-kg person must consume 75-100 cups of
coffee within a short period to achieve 10 mM caffeine in the
blood. The caffeine in this amount of coffee is about 10 g,
which is fatal in humans when taken all at once (28). There-
fore, whether the DNA-repair-inhibiting activity ofcaffeine is
significant for its pharmacological and toxicological effects
cannot be ascertained from the available data.
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